These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8102430)
1. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4. Lawrence R; Sorrell T Lancet; 1993 Aug; 342(8869):465-9. PubMed ID: 8102430 [TBL] [Abstract][Full Text] [Related]
3. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis. Lawrence RH; Sorrelli TC Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257 [TBL] [Abstract][Full Text] [Related]
4. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children. Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414 [TBL] [Abstract][Full Text] [Related]
5. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thomas SR; Ray A; Hodson ME; Pitt TL Thorax; 2000 Sep; 55(9):795-7. PubMed ID: 10950901 [TBL] [Abstract][Full Text] [Related]
6. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996 [TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. Schmitt-Grohé S; Zielen S Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023 [TBL] [Abstract][Full Text] [Related]
9. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400 [TBL] [Abstract][Full Text] [Related]
10. Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils. Kragballe K; Voorhees JJ; Goetzl EJ J Invest Dermatol; 1987 May; 88(5):555-8. PubMed ID: 2437212 [TBL] [Abstract][Full Text] [Related]
12. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Equi A; Balfour-Lynn IM; Bush A; Rosenthal M Lancet; 2002 Sep; 360(9338):978-84. PubMed ID: 12383667 [TBL] [Abstract][Full Text] [Related]
13. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641 [TBL] [Abstract][Full Text] [Related]
14. Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations. Aronoff SC; Quinn FJ; Carpenter LS; Novick WJ J Pediatr; 1994 Dec; 125(6 Pt 1):992-7. PubMed ID: 7996376 [TBL] [Abstract][Full Text] [Related]
15. In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid. Heidel JR; Taylor SM; Laegreid WW; Silflow RM; Liggitt HD; Leid RW Am J Pathol; 1989 Mar; 134(3):671-6. PubMed ID: 2538061 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Mickleborough TD; Lindley MR; Ionescu AA; Fly AD Chest; 2006 Jan; 129(1):39-49. PubMed ID: 16424411 [TBL] [Abstract][Full Text] [Related]
17. Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial. Vargas MH; Del-Razo-Rodríguez R; López-García A; Lezana-Fernández JL; Chávez J; Furuya MEY; Marín-Santana JC BMC Pulm Med; 2017 Dec; 17(1):206. PubMed ID: 29246256 [TBL] [Abstract][Full Text] [Related]
18. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Panchaud A; Sauty A; Kernen Y; Decosterd LA; Buclin T; Boulat O; Hug C; Pilet M; Roulet M Clin Nutr; 2006 Jun; 25(3):418-27. PubMed ID: 16325968 [TBL] [Abstract][Full Text] [Related]
19. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873 [TBL] [Abstract][Full Text] [Related]